These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22090038)

  • 1. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort.
    Drummond MB; Kirk GD; Astemborski J; Marshall MM; Mehta SH; McDyer JF; Brown RH; Wise RA; Merlo CA
    Thorax; 2012 Apr; 67(4):309-14. PubMed ID: 22090038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users.
    Drummond MB; Kirk GD; Astemborski J; McCormack MC; Marshall MM; Mehta SH; Wise RA; Merlo CA
    Int J Chron Obstruct Pulmon Dis; 2011; 6():89-95. PubMed ID: 21407821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.
    Drummond MB; Kirk GD; Ricketts EP; McCormack MC; Hague JC; McDyer JF; Mehta SH; Engels EA; Wise RA; Merlo CA
    BMC Pulm Med; 2010 May; 10():27. PubMed ID: 20459792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.
    Fischer WA; Drummond MB; Merlo CA; Thomas DL; Brown R; Mehta SH; Wise RA; Kirk GD
    COPD; 2014 Feb; 11(1):10-6. PubMed ID: 23862666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of obstructive lung disease in HIV population: a cross sectional study.
    Hirani A; Cavallazzi R; Vasu T; Pachinburavan M; Kraft WK; Leiby B; Short W; Desimone J; Squires KE; Weibel S; Kane GC
    Respir Med; 2011 Nov; 105(11):1655-61. PubMed ID: 21703841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with pulmonary impairment in HIV-infected South African adults.
    Gupte AN; Wong ML; Msandiwa R; Barnes GL; Golub J; Chaisson RE; Hoffmann CJ; Martinson NA
    PLoS One; 2017; 12(9):e0184530. PubMed ID: 28902919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients.
    Campo J; Del Romero J; Castilla J; García S; Rodríguez C; Bascones A
    J Oral Pathol Med; 2002 Jan; 31(1):5-10. PubMed ID: 11896816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort.
    Drummond MB; Merlo CA; Astemborski J; Kalmin MM; Kisalu A; Mcdyer JF; Mehta SH; Brown RH; Wise RA; Kirk GD
    AIDS; 2013 May; 27(8):1303-11. PubMed ID: 23299176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and proteinuria in an injection drug user population.
    Yanik EL; Lucas GM; Vlahov D; Kirk GD; Mehta SH
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1836-43. PubMed ID: 20705967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count.
    Vlahov D; Graham N; Hoover D; Flynn C; Bartlett JG; Margolick JB; Lyles CM; Nelson KE; Smith D; Holmberg S; Farzadegan H
    JAMA; 1998 Jan; 279(1):35-40. PubMed ID: 9424041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research.
    Rompalo AM; Astemborski J; Schoenbaum E; Schuman P; Carpenter C; Holmberg SD; Warren DL; Farzadegan H; Vlahov D; Smith DK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):448-54. PubMed ID: 10225226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection is associated with reduced pulmonary diffusing capacity.
    Crothers K; McGinnis K; Kleerup E; Wongtrakool C; Hoo GS; Kim J; Sharafkhaneh A; Huang L; Luo Z; Thompson B; Diaz P; Kirk GD; Rom W; Detels R; Kingsley L; Morris A
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):271-8. PubMed ID: 23979001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between CD4
    Islam M; Ramesh N; Kolman S; Koshy S; Frank M; Salomon N; Miller A; Harris M
    Lung; 2017 Oct; 195(5):635-642. PubMed ID: 28647827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delays in protease inhibitor use in clinical practice.
    Fairfield KM; Libman H; Davis RB; Eisenberg DM
    J Gen Intern Med; 1999 Jul; 14(7):395-401. PubMed ID: 10417596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California.
    Koslik HJ; Joshua J; Cuevas-Mota J; Goba D; Oren E; Alcaraz JE; Garfein RS
    Drug Alcohol Depend; 2020 Sep; 214():108158. PubMed ID: 32652379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study.
    Kayongo A; Wosu AC; Naz T; Nassali F; Kalyesubula R; Kirenga B; Wise RA; Siddharthan T; Checkley W
    COPD; 2020 Jun; 17(3):297-305. PubMed ID: 32462945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection.
    Leung JM; Liu JC; Mtambo A; Ngan D; Nashta N; Guillemi S; Harris M; Lima VD; Mattman A; Shaipanich T; Raju R; Hague C; Leipsic JA; Sin DD; Montaner JS; Man SF
    AIDS Patient Care STDS; 2014 May; 28(5):240-7. PubMed ID: 24742270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung function and atherosclerosis: a cross-sectional study of multimorbidity in rural Uganda.
    Gilbert RF; Cichowitz C; Bibangambah P; Kim JH; Hemphill LC; Yang IT; Sentongo RN; Kakuhikire B; Christiani DC; Tsai AC; Okello S; Siedner MJ; North CM
    BMC Pulm Med; 2022 Jan; 22(1):12. PubMed ID: 34983492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.
    Fu TC; Westergaard RP; Lau B; Celentano DD; Vlahov D; Mehta SH; Kirk GD
    AIDS; 2012 Nov; 26(18):2383-91. PubMed ID: 23079804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function in men with and without HIV.
    Kunisaki KM; Nouraie M; Jensen RL; Chang D; D'Souza G; Fitzpatrick ME; McCormack MC; Stosor V; Morris A
    AIDS; 2020 Jul; 34(8):1227-1235. PubMed ID: 32287070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.